Home » Archive

Articles in the Pharmaceutical Manufacturing Category

Pharmaceutical Manufacturing »

[22 Feb 2009 | 2 Comments | 93 views]
From Bench to Bedside

How long do you think it takes from the time the drug is discovered to the time it comes in the market?
In 2002, survey found that the average time for the development of a drug is about 12 years and 10 months, and only 1 in 10 drugs are able to make it to the [...]

Pharmaceutical Manufacturing »

[12 Feb 2009 | No Comment | 118 views]
Forging the BioFuture

Come and be part of our team to forge the Biofuture!
-Prof Miranda Yap Executive Director, BTI

What is BTI?
The Bioprocessing Technology Institute (BTI) is one of the institutes under the Agency of Science, Technology and Research (A*Star).  At BTI, researchers and scientists pursue innovative and cutting-edge research in bioprocess and engineering that develop technologies to impact [...]

Pharmaceutical Manufacturing »

[6 Feb 2009 | No Comment | 111 views]
Moving Towards Process Optimization

“Every patient is special.”

This is the foundation behind drug development and production. The pharmaceutical industry has to follow heavy regulations and guidelines to ensure the products are safe for consumption and the process adopted for manufacturing is reliable. The nature of this industry calls for the highest standards of production precision and accurate product and [...]

Pharmaceutical Manufacturing »

[6 Feb 2009 | No Comment | 86 views]
BTI partners GSK

A*STAR’s Bioprocessing Technology Institute (BTI) and GSK Biologicals SA Belgium have recently sealed an agreement to collaborate in three vaccine and adjuvant system related research projects. This partnership aims to bring new approaches to vaccine development and production.
With biologics becoming increasingly profitable with growth in sales doubling that of traditional pharmaceuticals, BTI’s work on characterizing [...]

Pharmaceutical Manufacturing »

[3 Feb 2009 | 2 Comments | 1,006 views]
Good news from GSK, but is it enough?

US pharmaceutical giant GlaxoSmithKline (GSK) brings good news to Singapore, beyond the Ribena and Panadol (yes, they are the ones bringing you your familiar consumer health care products, vaccines and prescription medicine).
On 26 January 2008, during Prime Minister Lee Hsien Loong’s visit to its Jurong plant, GSK announced that it will invest another $100 million [...]